Attached files

file filename
EX-32.2 - EX-32.2 - ABBOTT LABORATORIESa17-8899_1ex32d2.htm
EX-32.1 - EX-32.1 - ABBOTT LABORATORIESa17-8899_1ex32d1.htm
EX-31.2 - EX-31.2 - ABBOTT LABORATORIESa17-8899_1ex31d2.htm
EX-31.1 - EX-31.1 - ABBOTT LABORATORIESa17-8899_1ex31d1.htm
EX-4.7 - EX-4.7 - ABBOTT LABORATORIESa17-8899_1ex4d7.htm
10-Q - 10-Q - ABBOTT LABORATORIESa17-8899_110q.htm

Exhibit 12

 

Abbott Laboratories and Subsidiaries

 

Computation of Ratio of Earnings to Fixed Charges

 

(Unaudited)

 

(dollars in millions)

 

 

 

Three Months Ended

 

 

 

March 31, 2017

 

Earnings from Continuing Operations

 

$

386

 

Add (deduct):

 

 

 

Taxes on earnings

 

350

 

Capitalized interest cost, net of amortization

 

(4

)

Noncontrolling interests

 

3

 

 

 

 

 

Earnings from Continuing Operations, as adjusted

 

735

 

 

 

 

 

Fixed Charges:

 

 

 

Interest on long-term and short-term debt

 

226

 

Capitalized interest cost

 

7

 

Rental expense representative of an interest factor

 

30

 

 

 

 

 

Total Fixed Charges

 

263

 

 

 

 

 

Total adjusted earnings available for payment of fixed charges

 

$

998

 

 

 

 

 

Ratio of earnings to fixed charges

 

3.8

 

 

NOTE:   For the purpose of calculating this ratio, (i) earnings from continuing operations have been calculated by adjusting earnings for taxes on earnings; interest expense; capitalized interest cost, net of amortization; noncontrolling interests; and the portion of rentals representative of the interest factor, (ii) Abbott considers one-third of rental expense to be the amount representing return on capital, and (iii) fixed charges comprise total interest expense, including capitalized interest and such portion of rentals.

 

1